To explore the ethical implications and access disparities associated with longevity medicine, particularly in relation to socioeconomic factors.
Approach:
Key Findings:
Longevity medicine aims to extend health span through personalized, preventive care.
Access to longevity medicine is stratified by socioeconomic status, risking increased health inequities and highlighting the need for equitable access.
A significant portion of the population desires to live longer only if they remain healthy, highlighting the importance of health span over lifespan.
Interpretation:
The integration of longevity medicine must address ethical concerns regarding access and equity to prevent widening health disparities.
Limitations:
Current longevity medicine interventions are largely inaccessible to lower-income populations due to high costs and lack of standardization.
High health literacy is required to effectively utilize longevity medicine, which is typically lacking in disadvantaged groups.
Conclusion:
The integration of longevity medicine requires intentional policies to ensure equitable access and prevent deepening health inequities.
In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.